Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01381978
Other study ID # DIUC
Secondary ID
Status Completed
Phase N/A
First received June 23, 2011
Last updated May 21, 2012
Start date October 2010

Study information

Verified date May 2012
Source Universidad de Cuenca
Contact n/a
Is FDA regulated No
Health authority Ecuador: Ethical Committee
Study type Observational

Clinical Trial Summary

Hypothesis: Obesity in children of Cuenca is related with socioeconomical status and physical activity habits.

Summary:

The prevalence of obesity and overweigh in all age groups are increasing rapidly in the world. Some factors like physical activity, socioeconomical status, dietary habits, gender, besides genetic factors influence in the development of obesity.

In Cuenca - Ecuador lack information related to prevalence of overweight and obesity in children and the risk factors related.

Socioeconomical status and quality of physical activity are assessed using specially designed questionnaires in a randomized sample of children 6 to 9 years of age of Cuenca city. Nutritional status is assessed using body mass index, relation weight/age and height/age. These data are helpful to develop programs focused to improve nutritional status in scholars of Cuenca.


Recruitment information / eligibility

Status Completed
Enrollment 700
Est. completion date
Est. primary completion date
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 6 Years to 9 Years
Eligibility Inclusion Criteria:

- All children of selected sample with an approved consent by their parents

Exclusion Criteria:

- Children with malformations that not permit take anthropometric measures.

Study Design

Time Perspective: Cross-Sectional


Related Conditions & MeSH terms


Locations

Country Name City State
Ecuador Universidad de Cuenca Cuenca Azuay

Sponsors (3)

Lead Sponsor Collaborator
Universidad de Cuenca Universiteit Antwerpen, University Rovira i Virgili

Country where clinical trial is conducted

Ecuador, 

See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2